v3.26.3
Divestitures - Narrative (Details)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2026
USD ($)
Jun. 30, 2026
USD ($)
Sep. 30, 2025
USD ($)
Sep. 30, 2026
USD ($)
Sep. 30, 2025
USD ($)
Aug. 03, 2026
USD ($)
Oct. 01, 2023
product
Disposal Group, Including Discontinued Operations [Line Items]              
(Gain) Loss on disposition of business       $ (13.9) $ (79.1)    
Product Rights              
Disposal Group, Including Discontinued Operations [Line Items]              
Intangible asset, impairment loss $ (0.8) $ 177.8          
Disposal Group, Disposed of by Sale, Not Discontinued Operations              
Disposal Group, Including Discontinued Operations [Line Items]              
Number of women's healthcare product rights sold | product             2
Disposal Group, Held-for-Sale or Disposed of by Sale, Not Discontinued Operations | Income Statement Location [Axis]: us-gaap:OtherNonoperatingIncomeExpense              
Disposal Group, Including Discontinued Operations [Line Items]              
(Gain) Loss on disposition of business     $ (1.6) $ 13.9 $ 79.1    
Product Rights | Disposal Group, Held-for-Sale or Disposed of by Sale, Not Discontinued Operations              
Disposal Group, Including Discontinued Operations [Line Items]              
Upfront consideration           $ 30.0  
Potential contingent sales milestones           $ 70.0